Showing results (1-10 of 62) with videos related to
Sort By:
Pageof 7
Cancer Management and Research|December 29, 2010
Role of EGF inhibitors in the treatment of recurrent or metastatic squamous cell head and neck cancerJochen H LorchFrontiers in Oncology|March 3, 2025
Are all programmed cell death protein 1 inhibitors the same?Jochen H Lorch, Stacey Stein, Martin J EdelmanSurgical Pathology Clinics|November 2, 2019
Treatment of Aggressive Thyroid CancerJulian Huang, Ethan James Harris, Jochen H LorchThe Oncologist|February 28, 2013
Induction chemotherapy for locoregionally advanced head and neck cancer: past, present, future?Glenn J Hanna, Robert I Haddad, Jochen H LorchCancer Research|January 20, 2007
Bortezomib inhibits cell-cell adhesion and cell migration and enhances epidermal growth factor receptor inhibitor-induced cell death in squamous cell cancerJochen H Lorch, Tarita O Thomas, Hans-Joachim SchmollHematology/Oncology Clinics of North America|November 18, 2008
Induction chemotherapy in locally advanced head and neck cancer: a new standard of care?Jochen H Lorch, Marshall R Posner, Lori J Wirth, et al.Histopathology|May 20, 2020
Histological features of BRAF V600E-mutant anaplastic thyroid carcinomaTiffany Y Chen, Jochen H Lorch, Kristine S Wong, et al.Surgery|November 20, 2012
Autophagic activation potentiates the antiproliferative effects of tyrosine kinase inhibitors in medullary thyroid cancerChi-Iou Lin, Edward E Whang, Jochen H Lorch, et al.Oral Oncology|November 26, 2008
Seeking alternative biological therapies: the future of targeted molecular treatmentJochen H Lorch, Marshall R Posner, Lori J Wirth, et al.Surgery|September 16, 2019
Ketogenic diet combined with antioxidant N-acetylcysteine inhibits tumor growth in a mouse model of anaplastic thyroid cancerAbha Aggarwal, Zuliang Yuan, Justine A Barletta, et al.Pageof 7